Neonatal subgaleal hemorrhage: twenty years of trends in incidence, associations, and outcomes.
J Perinatol 2022;
43:573-577. [PMID:
36307481 DOI:
10.1038/s41372-022-01541-z]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 10/05/2022] [Accepted: 10/12/2022] [Indexed: 11/08/2022]
Abstract
BACKGROUND
In 2011, we reported 38 neonates with subgaleal hemorrhage (SH), relating an increasing incidence. It is unclear whether the incidence in our hospitals continued to rise and which risk factors and outcomes are associated with this condition.
DESIGN
We retrospectively analyzed every recognized case of SH in our hospitals from the end of our previous report (2010) to the present (2022). We redescribed the incidence, scored severity, tabulated blood products transfused, and recorded outcomes.
RESULTS
Across 141 months, 191 neonates were diagnosed with SH; 30 after vacuum or forceps. The incidence (one/1815 births) was higher than in our 2011 report (one/7124 births). Also, severe SH (requiring transfusion) was more common (one/10,033 births vs. one/20,950 births previously). Four died (all with severe SH) and 12 had neurodevelopmental impairment.
CONCLUSION
Recognized cases of SH are increasing in our system without a clear explanation. Adverse outcomes are rare but continue to occur.
Collapse